Literature DB >> 21703668

Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions.

Kenneth M Peters1, Kim A Killinger, Mark H Mounayer, Judith A Boura.   

Abstract

OBJECTIVES: Coexisting conditions associated with interstitial cystitis/painful bladder syndrome (IC/PBS) have not been fully explored by IC/PBS subtypes. We compared comorbid diagnoses/symptoms in women with ulcerative (ULC) and nonulcerative (N-ULC) IC/PBS and controls.
METHODS: Adult women with IC/PBS and controls without IC/PBS completed a mailed survey assessing for 21 diagnoses. IC/PBS subtype was determined by hydrodistention reports. Standardized questionnaires assessed IC/PBS symptoms (Interstitial Cystitis Symptom/Problem Indexes [ICSI-PI]) and for undiagnosed fibromyalgia, irritable bowel syndrome, and depression (Symptom Intensity Score [SIS]; Rome III Functional Bowel Questionnaire; Center for Epidemiologic Studies Depression Scale [CES-D]). Data were analyzed using the Pearson chi-square, Fisher exact, Wilcoxon rank test, or Spearman rank correlation coefficient.
RESULTS: Of 178 N-ULC IC/PBS patients, 36 ULC IC/PBS patients, and 425 controls, ULC IC/PBS subjects were older (median 63 years; P < .01) and less employed (P < .01), but groups were similar on other demographic characteristics. N-ULC reported more chronic diagnoses (mean 3.5 ± 2.3) than ULC (2.3 ± 2.0) and controls (1.2 ± 1.5) (P < .01). When N-ULC and ULC IC/PBS patients were compared, more N-ULC IC/PBS patients had fibromyalgia (P = .03), migraines (P = .03), temporomandibular joint disorder (P < .01), and higher CES-D (P = .02) and SIS scores (P = .01). The ULC IC/PBS group voided more frequently during the daytime (P = .03) and nighttime (P < .01) and had smaller mean bladder capacity than N-ULC (P < .01). No significant differences were seen between N-ULC and ULC IC/PBS patients on the ICSI-PI and Rome III.
CONCLUSIONS: Notable differences in the number of comorbid diagnoses and symptoms were seen between IC/PBS subtypes and controls. Subtypes should continue to be evaluated individually to ascertain other similarities and differences.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21703668     DOI: 10.1016/j.urology.2011.04.030

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  23 in total

1.  Risk of associated conditions in relatives of subjects with interstitial cystitis.

Authors:  Kristina Allen-Brady; Peggy A Norton; Lisa Cannon-Albright
Journal:  Female Pelvic Med Reconstr Surg       Date:  2015 Mar-Apr       Impact factor: 2.091

2.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

3.  Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis.

Authors:  Pradeep Tyagi; Kim Killinger; Vikas Tyagi; Jayabalan Nirmal; Michael Chancellor; Kenneth M Peters
Journal:  J Urol       Date:  2012-04-13       Impact factor: 7.450

Review 4.  A systematic review of the literature on cystodistension in bladder pain syndrome.

Authors:  Louise E Olson; James E Dyer; Ahsanul Haq; Jeremy Ockrim; Tamsin J Greenwell
Journal:  Int Urogynecol J       Date:  2017-05-26       Impact factor: 2.894

Review 5.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

6.  [The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients].

Authors:  D Jocham; G Froehlich; F Sandig; A Ziegler
Journal:  Urologe A       Date:  2013-05       Impact factor: 0.639

7.  Pain in interstitial cystitis/bladder pain syndrome: do characteristics differ in ulcerative and non-ulcerative subtypes?

Authors:  Kim A Killinger; Judith A Boura; Kenneth M Peters
Journal:  Int Urogynecol J       Date:  2012-12-04       Impact factor: 2.894

8.  General health status and incidence of first-onset temporomandibular disorder: the OPPERA prospective cohort study.

Authors:  Anne E Sanders; Gary D Slade; Eric Bair; Roger B Fillingim; Charles Knott; Ronald Dubner; Joel D Greenspan; William Maixner; Richard Ohrbach
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

9.  Treatment of ulcerative compared to non-ulcerative interstitial cystitis with hyperbaric oxygen: a pilot study.

Authors:  David L Wenzler; Farris Gulli; Maureen Cooney; Michael B Chancellor; Jason Gilleran; Kenneth M Peters
Journal:  Ther Adv Urol       Date:  2017-09-29

10.  Current best practice management of interstitial cystitis/bladder pain syndrome.

Authors:  Esther Han; Laura Nguyen; Larry Sirls; Kenneth Peters
Journal:  Ther Adv Urol       Date:  2018-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.